July 31, 2020
Attorneys at Glancy Prongay & Murray LLP representing investors in a $50 million settlement with medical device company Zimmer Biomet Holdings Inc. asked an Indiana federal judge on Thursday to approve its request of $18.2 million in attorney fees and expenses.
April 14, 2020
Medical device company Zimmer Biomet Holdings Inc. has agreed to pay $50 million to end investor claims it intentionally hid compliance problems at a critical manufacturing facility, thereby hurting its shareholders.
April 12, 2019
Zimmer Biomet Holdings Inc. investors asked an Indiana federal court for class certification in their suit accusing the medical device manufacturer of intentionally hiding compliance problems at a major factory, which they say led to substantial stock drops when the issues were revealed.
September 28, 2018
An Indiana federal judge has dismissed insider trading claims against 18 private equity firms but otherwise left intact a proposed investor class action alleging medical device manufacturer Zimmer Biomet knowingly concealed compliance issues at a key factory that, when disclosed, led to substantial stock drops.